Inovio Pharmaceuticals
INO
#8887
Rank
โ‚ฌ0.12 B
Marketcap
1,81ย โ‚ฌ
Share price
-1.84%
Change (1 day)
-52.60%
Change (1 year)

EPS for Inovio Pharmaceuticals (INO)

EPS in 2025 (TTM): -2,53ย โ‚ฌ

According to Inovio Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -2,45ย โ‚ฌ. In 2024 the company made an earnings per share (EPS) of -3,36ย โ‚ฌ an increase over its 2023 EPS that were of -5,19ย โ‚ฌ.

EPS history for Inovio Pharmaceuticals from 1999 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-2,53ย โ‚ฌ-24.8%
2024-3,36ย โ‚ฌ-35.14%
2023-5,19ย โ‚ฌ-56.62%
2022-11,96ย โ‚ฌ-19.54%
2021-14,86ย โ‚ฌ35.9%
2020-10,93ย โ‚ฌ-11.57%
2019-12,36ย โ‚ฌ15.24%
2018-10,73ย โ‚ฌ-2.78%
2017-11,04ย โ‚ฌ6.93%
2016-10,32ย โ‚ฌ134.88%
2015-4,39ย โ‚ฌ-29.51%
2014-6,23ย โ‚ฌ-57.34%
2013-14,61ย โ‚ฌ146.55%
2012-5,93ย โ‚ฌ20.83%
2011-4,90ย โ‚ฌ-29.41%
2010-6,95ย โ‚ฌ-48.48%
2009-13,49ย โ‚ฌ10%
2008-12,26ย โ‚ฌ11.11%
2007-11,04ย โ‚ฌ-41.3%
2006-18,80ย โ‚ฌ-66.91%
2005-56,81ย โ‚ฌ110.61%
2004-26,98ย โ‚ฌ-61.63%
2003-70,30ย โ‚ฌ186.67%
2002-24,52ย โ‚ฌ
2001N/A-100%
2000-19,62ย โ‚ฌ-63.26%
1999-53,39ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
1,46ย โ‚ฌ-159.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
8,89ย โ‚ฌ-462.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
-1,06ย โ‚ฌ-56.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
6,27ย โ‚ฌ-355.56%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
6,47ย โ‚ฌ-363.67%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
3,06ย โ‚ฌ-224.86%๐Ÿ‡ฌ๐Ÿ‡ง UK
Gilead Sciences
GILD
5,55ย โ‚ฌ-326.39%๐Ÿ‡บ๐Ÿ‡ธ USA